Trump’s ‘Most Favoured Nation’ drug policy could reshape trade with Indian pharma
Washington, Dec 18, (IANS) US President Donald Trump’s announcement of sweeping prescription drug price cuts under a “Most Favoured Nation” policy has put India’s pharmaceutical industry in focus, as Washington moves to benchmark US drug prices against those paid in other countries.